News
ELAN
19.86
-8.23%
-1.78
Elanco price target lowered to $23 from $24 at Morgan Stanley
TipRanks · 15h ago
Morgan Stanley Reaffirms Their Hold Rating on Elanco Animal Health (ELAN)
TipRanks · 18h ago
Elanco to Participate in Upcoming Investor Conferences
PR Newswire · 1d ago
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH), Elanco Animal Health (ELAN) and Align Tech (ALGN)
TipRanks · 4d ago
Weekly Report: what happened at ELAN last week (0504-0508)?
Weekly Report · 4d ago
Why Elanco (ELAN) Is Up 7.3% After Raising 2026 Revenue Guidance On New Product Momentum
Simply Wall St · 5d ago
Results: Elanco Animal Health Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates
Simply Wall St · 05/08 14:29
Elanco Animal Health Is Maintained at Buy by Citigroup
Dow Jones · 05/07 21:10
Elanco Animal Health Price Target Raised to $31.00/Share From $30.00 by Citigroup
Dow Jones · 05/07 21:10
Citigroup Maintains Buy on Elanco Animal Health, Raises Price Target to $31
Benzinga · 05/07 21:00
Elanco Animal Health Is Maintained at Overweight by JP Morgan
Dow Jones · 05/07 19:17
Elanco Animal Health Price Target Raised to $30.00/Share From $28.00 by JP Morgan
Dow Jones · 05/07 19:17
JP Morgan Maintains Overweight on Elanco Animal Health, Raises Price Target to $30
Benzinga · 05/07 19:07
Elanco Animal Health Down Over 7%, on Pace for Largest Percent Decrease Since April 2025 -- Data Talk
Dow Jones · 05/07 19:06
Elanco price target raised to $30 from $28 at JPMorgan
TipRanks · 05/07 15:37
Elanco price target raised to $31 from $30 at Citi
TipRanks · 05/07 11:13
Elanco raises FY26 adjusted EPS view to $1.03-$1.09 from $1.00-$1.06
TipRanks · 05/07 09:37
Elanco Earnings Call Highlights Innovation-Led Growth
TipRanks · 05/07 01:11
Elanco Animal Health Q1 Profit Reignites Debate On Path To Sustainable Earnings
Simply Wall St · 05/07 00:47
Elanco outlines 5%-7% organic growth and $1.03-$1.09 adjusted EPS as innovation target rises to $1.2B
Seeking Alpha · 05/06 21:42
More
Webull provides a variety of real-time ELAN stock news. You can receive the latest news about Elanco Animal Health through multiple platforms. This information may help you make smarter investment decisions.
About ELAN
Elanco Animal Health Incorporated is an animal health company. The Company is engaged in delivering products and services to prevent and treat disease in farm animals and pets. It serves animals across species, including dogs, cats, cattle, poultry, swine and sheep. Its pet health products help pets live longer, healthier and more active lives. Its pet health portfolio is focused on parasiticides, dermatology, vaccines and pain/other therapeutics. It includes parasiticide portfolios in the pet health market based on indications, species and formulations, with products that protect pets from fleas, ticks and internal parasites. It offers Advantage, K-9 Advantix, Advocate, and AdTab, which are over-the-counter treatments for the prevention and elimination of fleas and ticks. Its farm animal products help producers improve animal health and wellbeing. It offers a farm animal portfolio of products for cattle including beef and dairy, poultry, swine and sheep.